We’ve put some small files called cookies on your device to make our site work.
We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We’ll use a cookie to save your choice. You can read more about our cookies before you choose.
Change my preferences
I'm OK with analytics cookies
Patient Group Direction (PGD) for the initial supply of ciprofloxacin 500mg tablets to adults and children aged 12 years and over with known or suspected exposure to plague (Yersinia pestis).
Updated January 2022.